title: Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
abstract: While there are currently no medications approved for methamphetamine (METH) addiction, it has been shown that propentofylline (PPF), an atypical methylxanthine, can suppress the rewarding effects of methamphetamine (METH) in mice. This experiment studied the interactions of PPF with METH in striatal dopaminergic transmission. Herein, the impact of PPF (10-40mM, intrastriatally perfused (80min) on the effect of METH (5mg/kg, i.p.) on striatal dopamine (DA) release was evaluated using brain microdialysis in Sprague-Dawley adult rats. METH was injected at the 60min time point of the 80min PPF perfusion. The extracellular levels of DA and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were determined using high performance liquid chromatography with electrochemical detection (HPLC-ED). PPF induced a concentration-dependent increase in DA release beginning 30min after the onset of PPF perfusion. DA peak levels evoked by 40mM PPF were similar to those induced by 5mg/kg METH i.p. Only the highest concentration of PPF decreased the METH-induced DA peak (circa 70%). The significant decreases in extracellular levels of DOPAC and HVA evoked by METH were partially blocked by 10 and 20mM PPF. Although 40mM of PPF also partially blocked the METH-induced DOPAC decrease, it completely blocked HVA depletion after a transient increase in HVA levels in METH-treated rats. Data indicates for the first time that while PPF increases presynaptic striatal DA dynamics it attenuates METH-induced striatal DA release and metabolism.
authors: Div. of Neurotoxicology, NCTR/FDA, Jefferson, AR, USA.
authors: B
authors: B
authors: Gough
authors: Farmacologia e Terapêutica Experimental/IBILI, Faculdade de Medicina da Univ. de Coimbra, Coimbra, Portugal. Electronic address: fredcp@ci.uc.pt.
authors: F C
authors: FC
authors: Pereira
authors: Farmacologia e Terapêutica Experimental/IBILI, Faculdade de Medicina da Univ. de Coimbra, Coimbra, Portugal.
authors: C A
authors: CA
authors: Fontes Ribeiro
authors: Div. of Neurotoxicology, NCTR/FDA, Jefferson, AR, USA.
authors: S F
authors: SF
authors: Ali
authors: Div. of Neurotoxicology, NCTR/FDA, Jefferson, AR, USA. Electronic address: zbigniew.binienda@fda.hhs.gov.
authors: Z K
authors: ZK
authors: Binienda
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D017551:Microdialysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D014970:Xanthines / Q000494:pharmacology*
chemical_list: D014970:Xanthines; D008694:Methamphetamine; C032114:propentofylline; D004298:Dopamine
keywords: Caudate nucleus; Dopamine; In vivo microdialysis; Methamphetamine; Propentofylline